| Literature DB >> 27562914 |
Toshiaki Nakano1, Daiju Fukuda1, Jun-Ichiro Koga1, Masanori Aikawa2.
Abstract
The Notch signaling pathway regulates the development of various cell types and organs, and also contributes to disease mechanisms in adults. Accumulating evidence suggests its role in cardiovascular and metabolic diseases. Notch signaling components also control the phenotype of immune cells. Delta-like ligand 4 (Dll4) of the Notch pathway promotes proinflammatory activation of macrophages in vitro and in vivo. Dll4 blockade attenuates chronic atherosclerosis, vein graft disease, vascular calcification, insulin resistance, and fatty liver in mice. The Dll4-Notch axis may, thus, participate in the shared mechanisms for cardiometabolic disorders, serving as a potential therapeutic target for ameliorating these global health problems.Entities:
Keywords: atherosclerosis; fatty liver; inflammation; macrophage; metabolic disease; veins
Mesh:
Substances:
Year: 2016 PMID: 27562914 PMCID: PMC5033717 DOI: 10.1161/ATVBAHA.116.306926
Source DB: PubMed Journal: Arterioscler Thromb Vasc Biol ISSN: 1079-5642 Impact factor: 8.311